久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Companies

Novo Nordisk sees ample room for further expansion in nation

By LIU ZHIHUA | China Daily | Updated: 2021-06-08 09:14
Share
Share - WeChat
Employees work on the production line of a Novo Nordisk venture in Tianjin. [Provided to China Daily]

China's sustained efforts to improve the business environment and encourage innovation will boost its long-term growth prospects and create ample expansion opportunities for foreign businesses, according to a senior pharmaceutical company official.

Lars Fruergaard Jorgensen, president and CEO of Denmark-based biopharmaceutical company Novo Nordisk, said he was confident about long-term growth in the country.

"We are fully confident that the Chinese economy will maintain growth. The 14th Five-Year Plan (2021-25) will serve as a roadmap for economic and social development and help sustain high-quality growth. With a supportive business environment, we are confident that Novo Nordisk, along with other foreign businesses, will enjoy long-term success in the country."

Novo Nordisk, a global leader in diabetes care, will continue to invest in a sustainable and innovation-based healthcare ecosystem in China, he said.

As China enters a new development phase featuring the dual-circulation development paradigm, which takes the domestic market as the mainstay while letting domestic and foreign markets reinforce each other, there will be significant opportunities for the company to continue enhancing its presence across the whole value chain and strengthen innovation and production capabilities to fulfill the growing needs of people with diabetes in China and globally, said Jorgensen.

China's strong economic recovery since COVID-19 is impressive, said Jorgensen, adding that Novo Nordisk's unit in the country gained significantly due to the robust domestic demand.

China has been leaving no stone unturned to deepen reforms, pursue higher-level opening-up and improve business environment, as part of its broader push to ensure high-quality development. Thanks to its robust economic performance and continuously improving business environment, foreign investors' enthusiasm in the country has been increasing steadily, experts said.

According to a recent survey conducted by the Ministry of Commerce, 96.4 percent of the more than 3,200 surveyed foreign-invested companies had a positive attitude toward future business prospects in China, up 2.1 percentage points from the beginning of this year.

Data from the ministry showed that China's actual use of foreign investment during the January-April period rose 38.6 percent on a yearly basis to 397.07 billion yuan ($62.27 billion). The total FDI value grew by 30.1 percent over the same period in 2019.

In the healthcare sector, a series of major policy reforms have been introduced since 2015, to encourage innovation, speed up new drug registration, and enhance the dynamic adjustment mechanism for the national reimbursement drug list, so as to improve quality healthcare accessibility and affordability.

According to the 14th Five-Year Plan and long-range objectives through 2035, China will continue to improve the fast-track review and approval mechanism for innovative medicines, vaccines and medical devices, so as to accelerate review and approval of medicines and medical devices for urgent clinical use and rare disease treatment.

Novo Nordisk has already established a full value chain in the country, with one of its biggest manufacturing bases in Tianjin that supplies both Chinese and international markets with durable devices for insulin injection and insulin products.

With its China Essentials program launched and updated in 2020, the company has integrated China into its latest global clinical development, aiming to achieve simultaneous submission for global new drug applications in the country.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 日韩经典在线观看 | 欧美亚洲国产日韩一区二区三区 | 亚洲第一页在线播放 | 性久久久久久久 | 亚洲免费在线观看 | 欧美精品高清 | 波多野结衣在线播放 | 97人摸人人澡人人人超一碰 | 日韩久久一级毛片 | 99国产精品久久久久久久成人热 | 亚洲成人一级 | 国产在线精品一区二区不卡 | 9久9久热精品视频在线观看 | 欧美亚洲日本一区二区三区浪人 | 欧美日韩视频二区三区 | 韩日一区二区 | 三级黄色片在线免费观看 | 成年人免费在线观看网站 | 天天摸天天爽视频69视频 | 亚洲国产成人久久笫一页 | 日本免费高清视频二区 | 直接在线观看的三级网址 | 亚洲精品国产国语 | 加勒比毛片 | 国产黄色一级毛片 | 免费看成人毛片日本久久 | 欧美视频在线一区 | 草草影院ccyycom浮力影院 | 国产成人综合网在线播放 | 在线成人天天鲁夜啪视频 | 国产精品久久久久激情影院 | 日本国产免费一区不卡在线 | 九九香蕉 | 国内视频一区二区 | 香港三澳门三日本三级 | 日韩精品在线看 | 亚洲国产第一区二区香蕉日日 | 日韩一级精品久久久久 | 久久一日本道色综合久久m 久久伊人成人网 | 欧美一级毛片美99毛片 | 男人的天堂在线 |